VELA RISKOPS

MEDSPA MARKETING RISK REVIEW

AI-assisted screening for GLP-1, Botox, before-and-after, review replies, and AI-generated medspa marketing.Not legal advice. Not a substitute for qualified counsel.

WHAT WE SCAN

HIGH-RISK MEDSPA CONTENT

Instagram captions, TikTok scripts, website pages, GLP-1 and semaglutide claims, Botox and filler promotions, before-and-after captions, patient testimonials, Google review replies, consent form language, and AI-generated staff content.

THE OFFER

$297 MARKETING RISK REVIEW

We review selected public marketing and patient-facing language, then provide a risk score, flagged issues, safer rewritten copy, and a 30-minute walkthrough. Findings are informational and intended to support your clinic’s internal compliance review.

CLEAR DELIVERABLES

We give you a risk score, specific flagged issues, detailed explanations for why those issues are risky, safer rewritten copy, a downloadable report, and an option for ongoing monthly monitoring. You know exactly what needs fixing and how to fix it.

WHY THIS MATTERS

APRIL 1, 2026 — THE FDA'S FIRST EVER
MEDSPA DSCSA WARNING LETTER
On April 1, 2026, the FDA issued its first-ever DSCSA warning letter to a medspa — Pure Indulgence Aesthetics in Southlake, Texas — citing Botox dispensing and documentation gaps. State medical boards in TX, FL, CA, NJ, and AZ are signaling parallel enforcement. A single warning letter can create six or more months of legal fees, mandatory remediation, and reputation damage. Vela RiskOps helps clinics surface common risk patterns in their public marketing before publication.

CONTACT US

EMAIL - [email protected]

READY TO REVIEW YOUR MARKETING RISK

Email us to schedule your $297 marketing risk review or ask about ongoing monitoring. We respond within one business day.

Important: Vela RiskOps is not a law firm and does not provide legal advice, legal opinions, or legal representation. Our service offers AI-assisted screening of public marketing content to support — not replace — your clinic's compliance, legal, and clinical leadership. We do not certify compliance with any federal, state, or local regulation. Use of our service does not create an attorney-client relationship. Customers agree to submit only public, non-PHI content. Final review by qualified counsel is required before relying on any output. Enforcement examples referenced on this site are drawn from public records and do not imply our service would have prevented those actions.

© 2026 Vela RiskOps · Privacy Policy · Terms of Service · Contact